Bibliographic Info
GuidelineHealth worker roles in providing safe abortion care and post-abortion contraception
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Context specific recommendation
Only in specific contexts
Women’s role in managing the process of medical abortion. Managing the mifepristone and misoprostol medication without direct supervision of a health-care provider: Recommended in specific circumstances
Notes and Remarks
- 1.We recommend this option in circumstances where women have a source of accurate information and access to a health-care provider should they need or want it at any stage of the process
- 2.A follow-up visit after MA using mifepristone–misoprostol is not mandatory. The efficacy of MA is lower when misoprostol alone is used; hence the self-assessment of completeness when misoprostol alone is used requires further research.
- 3.Available evidence for managing the medications and process without direct supervision of the provider is for pregnancy durations of nine weeks (63 days) or less.
- 4.Self-management approaches reflect an active extension of health systems and health care. These recommendations are NOT an endorsement of clandestine self-use by women without access to information or a trained health-care provider/health-care facility as a backup. All women should have access to health services should they want or need it.
- 5.Mechanisms to ensure access and linkages to post-abortion contraception services need to be established.
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO consolidated guideline on self-care interventions for health: sexual and reproductive health and rights
Year2019
InstitutionWHO
Guideline
WHO guideline on self-care interventions for health and well-being
Year2021
InstitutionWHO
Guideline
WHO guideline on self-care interventions for health and well-being, 2022 revision.
Year2022
InstitutionWHO